The Global Pre-Clinical Imaging (In Vivo) Market worth $1.55 Billion By 2017

The Global Pre-Clinical Imaging (In Vivo) Market worth $1.55 Billion By 2017 PR Newswire DALLAS, December 3, 2012 DALLAS, December 3, 2012 /PRNewswire/ -- The report "Global Pre-clinical Imaging (In vivo) Market By systems and reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT Multimodality/Hybrid Imaging Modalities] - Competitive Analysis Global Forecasts to 2017"- analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World. Browse 117 market data tables and 20 figures through 270 pages and in-depth TOC of "Pre-Clinical Imaging (In vivo) Market -By Systems and Reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro- Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017." http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market-841.html Early buyers will receive 10% customization on reports. This report studies the global pre-clinical imaging (in vivo) market over the forecast period of 2012-2017. The global pre-clinical imaging (in vivo) market is broadly segmented into two categories, namely, imaging systems and imaging reagents, and is expected to grow at a CAGR of 14.5% from 2012 to 2017. Imaging systems can be divided into standalone imaging systems and multimodal imaging systems.